(Q42118695)

16 October 2017

title

The pharmacokinetics of amikacin in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A874697

3 August 2022

1 reference

1 reference

Metabolic Clearance Rate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A874697

3 August 2022

author name string

B. Vogelstein

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A874697

3 August 2022

A. Kowarski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A874697

3 August 2022

P. S. Lietman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A874697

3 August 2022

language of work or name

English

0 references

publication date

1 August 1977

1 reference

The Journal of Pediatrics

16 October 2017

published in

1 reference

16 October 2017

volume

91

1 reference

16 October 2017

issue

2

1 reference

16 October 2017

page(s)

333-339

1 reference

Editorial: Gram-negative-rod bacteremia.

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Synthesis of 3'-deoxykanamycin effective against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Controlled Comparison of Amikacin and Gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Amikacin Therapy for Serious Gram-Negative Bacillary Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Amikacin therapy of infections in neutropenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Comparative pharmacokinetics of amikacin and kanamycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Pharmacology of amikacin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Pharmacological evaluation of amikacin in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Pharmacokinetics of Gentamicin in Children and Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Determination of Integrated Plasma Concentrations and True Secretion Rates of Human Growth Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Enzymatic acetylation as a means of determining serum aminoglycoside concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

The renal responses of infants and adults to the administration of hypertonic solutions of sodium chloride and urea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Increased Glomerular Filtration Rate in Hydrated Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Pancreatic excretion of erythromycin and kanamycin. Comparison of results obtained via a Thomas cannula and a duodenopancreaticopyelostoma in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Pharmacokinetics of Gentamicin: Distribution and Plasma and Renal Clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

Effects of change in elimination on varous parameters of the two-compartment open model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

The two-compartment open-system kinetic model: A review of its clinical implications and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980847-0

10.1016/S0022-3476(77)80847-0

7 January 2021

Identifiers

DOI

1 reference

16 October 2017

1 reference